The goal of therapy for noninfectious uveitis is to control inflammation while minimizing sequelae and side effects, according to one presenter at OSN New York Retina.
“We really don’t want to use long-term systemic corticosteroids, and we avoid as much as we can topical and local corticosteroids in young people,” Debra A. Goldstein, MD, FRCSC, said.
Corticosteroids are the most effective agent for initial control, Goldstein said, but if disease recurs during the tapering-off period, a transition to immunomodulatory therapy or long-acting local therapy should be instituted.
Uncategorized